Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:Fortune Drags Questions of Abby's Health from the Shadows Not Rated 2.6 Email Routing List Email & Route  Print Print
Friday, August 31, 2007

Fortune Drags Questions of Abby's Health from the Shadows

Reported by Sean Hanna, Editor in Chief

For nearly a year rumors that Abby Johnson is ill -- perhaps with cancer -- have wafted through the fund industry. This morning, Fortune became the first publisher to cross the line and make those rumors public.

Those rumors over the past year, which were widespread enough that even a spokesperson at a Fidelity rival had heard of them, included gossip that Abby was missing work for treatments and earlier this year that she had started wearing a wig. When The MFWire contacted Fidelity about the rumors last winter, a spokesperson told our reporter that she would not comment on the rumors. The spokesperson also added: "You're not going to print that, are you?"

We didn't, but Fortune has.

After apologizing that Abby's health would "not be Fortune's business" except for the recent "talent drain" at the mutual fund firm, reporter Patricia Sellers continues on:
Fidelity won't comment on Abby's health. But over the past year, say several executives who have worked with her, she has appeared to have undergone medical treatment and lost her hair -- as well as weight from her already slim frame. Today she no longer wears a wig; her hair has grown back and she looks healthy. In keeping with her stoic reputation, she has rarely missed work. But since she has not uttered a word about her health, not even to senior colleagues, no one knows if there was even an illness.
Fortune did not add a lot to the rumor mill. The article notes that Abby appears healthy and offers up an unrelated tidbit that Eric Schwartz, the former head of Goldman Sachs' investment management business, has received "overtures" from Fidelity. The source on the Schwartz report is the "buzz from Boston to New York." 

Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

2.6
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2024: Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly




©All rights reserved to InvestmentWires, Inc. 1997-2024
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use